STOCK TITAN
  1. Home
  2. News
  3. INMD

Inmode Ltd. - INMD STOCK NEWS

Welcome to our dedicated page for Inmode Ltd. news (Ticker: INMD), a resource for investors and traders seeking the latest updates and insights on Inmode Ltd. stock.

InMode Ltd. (NASDAQ: INMD) is a leading global provider of innovative medical technologies specializing in minimally and non-invasive surgical aesthetic and medical treatment solutions. The company's product portfolio spans three major energy-based treatment categories: face & body contouring, medical aesthetics, and women's health. Their products, such as BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, are widely utilized in plastic surgery, dermatology, gynecology, and ophthalmology.

InMode’s flagship products, including Fractora for skin texture improvement, Lumecca for photorejuvenation, Diolaze for hair removal, and BodyFX for body contouring, are designed to deliver effective and exciting aesthetic solutions.

InMode has consistently invested in research and development to expand its intellectual property portfolio, which is pivotal for maintaining its competitive edge. Recently, the company initiated legal action against BTL Industries for patent infringement regarding their radio-frequency based feminine rejuvenation products.

Despite market headwinds, including higher interest rates affecting equipment financing and slower purchase decisions, InMode has shown resilience with a 2% increase in Q3 2023 revenues, totaling $123.1 million. The company also saw a 13% rise in international sales during this period.

In Q1 2024, InMode announced pre-orders for two new platforms, IgniteRF and Optimus Max, which are anticipated to drive future growth. Additionally, a new share repurchase program and the appointment of Dr. Michael Anghel as Chairman of the Board underscore the company’s commitment to shareholder value.

InMode's innovative spirit is further highlighted by their recent partnership with P1 Offshore Racing, sponsoring the only female driver, Victoria Rand, signaling a strong commitment to empowering women.

For more detailed information and the latest updates, visit InMode's official website.

News

InMode Files Patent Infringement Complaint Against BTL Industries, Inc. (d/b/a BTL Aesthetics)

Rhea-AI Summary
InMode files patent infringement complaint against BTL Industries
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.37%
Tags
none
-
News

InMode Expects Third Quarter 2023 Revenue Between $122.8M-$123.0M, Lowering Full-Year 2023 Revenue Guidance to $500M-$510M vs. Original Estimates of $530M-$540M

Rhea-AI Summary
InMode Ltd. expects to release its financial results for Q3 2023 on Nov. 2, 2023. Preliminary results suggest a downtick in platform sales due to economic slowdown and financing constraints. Revenue for Q3 2023 is expected to be in the range of $122.8 million to $123.0 million. Non-GAAP earnings per diluted share for Q3 2023 are expected to be in the range of $0.59 to $0.60. Revenue for the full year of 2023 is expected to be in the range of $500 million to $510 million. Non-GAAP gross margin for Q3 2023 is expected to be in the range of 83% to 85%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.97%
Tags
earnings
-
News

InMode Affirms Safety of Management, Employees and Production Sites

Rhea-AI Summary
InMode Ltd. addresses the status of its activity in Israel, assuring no interruption to production and prioritizing employee safety. Inventory levels are sufficient for the next three quarters. Revenues generated from Israel account for less than 1%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.31%
Tags
none
News

InMode to Present at Upcoming Investor Conferences and Events

Rhea-AI Summary
InMode Ltd. announces participation in investor conferences and events in September.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.47%
Tags
conferences
-
News

InMode to Present at Upcoming Investor Conferences and Events

Rhea-AI Summary
InMode Ltd. to participate in investor conferences and events in August.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.17%
Tags
conferences
-
News

InMode Reports Second Quarter 2023 Financial Results; Record Quarterly Revenue of $136.1M Represents 20% Year-Over-Year Growth

Rhea-AI Summary
InMode Ltd. (Nasdaq: INMD) announced its second quarter 2023 financial results, reporting a record quarterly revenue of $136.1 million, a 20% increase from the same period last year. The company's proprietary surgical technology platforms accounted for 81% of revenues, with a 44% increase in consumables and service revenues. InMode also reported a record GAAP net income of $55.7 million and a non-GAAP net income of $62.2 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.15%
Tags
earnings
News

InMode Expands Women's Health and Wellness Market Footprint through Acquisition of Viveve Patents

Rhea-AI Summary
InMode Ltd. (Nasdaq: INMD) has completed a significant IP transaction in the women's health and wellness market, acquiring all intellectual property assets of Viveve Medical Inc. This acquisition, along with an exclusive licensing agreement with the University of California, solidifies InMode's position as the global market leader in women's wellness products development.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
acquisition
-
News

InMode Expects Second Quarter 2023 Revenue Between $135.7-$135.9M, Increases Full Year 2023 Guidance, Expects Revenues of $530-540M

Rhea-AI Summary
InMode Ltd., a global provider of medical technologies, will release its financial results for Q2 2023 on July 27, 2023. Preliminary results show expected revenue of $135.7 million to $135.9 million for Q2 2023, non-GAAP earnings per diluted share of $0.70 to $0.71, and full-year revenue guidance of $530 million to $540 million. The non-GAAP gross margin for Q2 2023 is expected to be in the range of 83% to 85%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11%
Tags
earnings
-
News

InMode to Present at Upcoming Investor Conferences and Events

Rhea-AI Summary
InMode Ltd. announced their participation in several upcoming investor conferences and events. They will be presenting at the BNPP Exane Aesthetics Day, the Barclays West Coast Bus Trip, and the Jefferies Healthcare Conference. The presentations will be led by key executives including the CEO, CFO, and Chief Medical Officer. The events will include virtual fireside chats, in-person investor bus tours, and one-on-one meetings. Webcasts of the presentations will be available for replay and live access.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.03%
Tags
conferences
News

InMode Reports First Quarter 2023 Financial Results; Quarterly Revenue of $106.1M Represents 23.5% Year-Over-Year Growth

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10%
Tags
earnings

FAQ

What is the current stock price of Inmode Ltd. (INMD)?

The current stock price of Inmode Ltd. (INMD) is $18.9 as of February 21, 2025.

What is the market cap of Inmode Ltd. (INMD)?

The market cap of Inmode Ltd. (INMD) is approximately 1.3B.

What products does InMode Ltd. offer?

InMode offers a range of innovative aesthetic solutions including BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8.

What are InMode's core business categories?

InMode's core business categories include face & body contouring, medical aesthetics, and women's health.

Which markets does InMode serve?

InMode serves markets including plastic surgery, dermatology, gynecology, and ophthalmology.

How did InMode perform in Q3 2023?

In Q3 2023, InMode reported revenues of $123.1 million, a 2% increase from the same period in 2022, and a 13% increase in international sales.

What are some of InMode's flagship products?

InMode's flagship products include Fractora, Lumecca, Diolaze, and BodyFX, offering solutions for skin texture improvement, photorejuvenation, hair removal, and body contouring.

What recent legal actions has InMode taken?

InMode filed a patent infringement complaint against BTL Industries concerning their radio-frequency based feminine rejuvenation products.

What new platforms has InMode recently announced?

InMode has announced pre-orders for two new platforms, IgniteRF and Optimus Max, expected to drive future growth.

Who is the new Chairman of InMode's Board?

Dr. Michael Anghel has been appointed as the new Chairman of InMode's Board, effective July 25, 2024.

What partnership has InMode recently entered into?

InMode partnered with P1 Offshore Racing and is sponsoring the only female driver, Victoria Rand, as part of Class 1.

Where can I find more information about InMode?

For more information and the latest updates, visit InMode's official website at https://inmodemd.com/.
Stock INMD logo
Inmode Ltd.

Nasdaq:INMD

INMD Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

INMD Stock Data

1.32B
59.78M
12.72%
62.69%
7.49%
Medical Devices
Healthcare
Link
Israel
Yokne'am